Peapod Lane Capital’s Fulcrum Therapeutics FULC Stock Holding History

Peapod Lane Capital’s Portfolio FULC Stock Details FULC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.05M	Buy	+285,798	New	+$1.74M	0.71%	56

Other funds holding FULC

Assenagon Asset Management

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Marquette Asset Management Minneapolis, Minnesota $779M AUM 23.4% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return

Castleview Partners Dallas, Texas $228M AUM 19.85% 1-Year Est. Return

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Peapod Lane Capital's FULC Position: Q2 2026 in Review

Peapod Lane Capital opened a new position in Fulcrum Therapeutics (FULC) in Q2 2026: 285,798 shares worth $1.05M. The stake represents 0.71% of the portfolio and ranks #56 among its holdings.

20 funds tracked by Wall St. Rank hold FULC as of Q2 2026.

Peapod Lane Capital held 285,798 shares of Fulcrum Therapeutics worth $1.05M as of Q2 2026.
Fulcrum Therapeutics was a new Peapod Lane Capital position in Q2 2026.
Fulcrum Therapeutics made up 0.71% of Peapod Lane Capital's portfolio in Q2 2026, its #56 holding.
20 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q2 2026.

Based on Peapod Lane Capital's 13F filing for Q2 2026, filed 27 Jul 2026.